Newsroom
Patent brings possible new heart failure treatment closer to reality
mai 30, 2018
Drs. Lynn Megeney, Duncan Stewart, Colin Suen, and Mohammad Abdul-Ghani have been granted a U.S. patent for an experimental approach to treat heart failure using a protein called cardiotrophin 1 (CT1). Heart failure is a leading cause of death and disability in high-income countries and occurs when the heart can’t pump enough blood through the body. A recent study showed that CT1 can trick the heart into growing in a healthy way and pumping more blood. The research team found that CT-1 dramatically improved heart function in two animal models of heart failure - one caused by a heart attack (affecting the left side of the heart) and one caused by high blood pressure in the lungs (pulmonary hypertension, affecting the right side of the heart). Drs. Megeney and Stewart hope to develop partnerships to test this protein in patients. If this testing is successful, it will take a number of years for the treatment to become widely available.
Image of heart cell treated with cardiotrophin 1 courtesy of Cell Research.
The Ottawa Hospital: Inspired by research. Driven by compassion
The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care. See www.ohri.ca for more information about research at The Ottawa Hospital.
University of Ottawa: —A crossroads of cultures and ideas
The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe. www.uottawa.ca
Media Contact
Amelia Buchanan
Senior Communication Specialist
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73687
Cell: 613-297-8315
ambuchanan@ohri.ca
